JP2014506249A - グリコフロールを含む経表面局所イソオキサゾリン製剤 - Google Patents

グリコフロールを含む経表面局所イソオキサゾリン製剤 Download PDF

Info

Publication number
JP2014506249A
JP2014506249A JP2013545417A JP2013545417A JP2014506249A JP 2014506249 A JP2014506249 A JP 2014506249A JP 2013545417 A JP2013545417 A JP 2013545417A JP 2013545417 A JP2013545417 A JP 2013545417A JP 2014506249 A JP2014506249 A JP 2014506249A
Authority
JP
Japan
Prior art keywords
methyl
solvent
transsurface
compound
ethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013545417A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014506249A5 (enExample
Inventor
フツクス，シユテフアン
ヘツケロト，アンヤ・レジーナ
ミユーラー，ラモナ
ビリアムス，ヘイケ
ゾラー，ハルトムート
Original Assignee
インターベツト・インターナシヨナル・ベー・ベー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43920659&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP2014506249(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by インターベツト・インターナシヨナル・ベー・ベー filed Critical インターベツト・インターナシヨナル・ベー・ベー
Publication of JP2014506249A publication Critical patent/JP2014506249A/ja
Publication of JP2014506249A5 publication Critical patent/JP2014506249A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/72—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
    • A01N43/80—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,2
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plant Pathology (AREA)
  • Wood Science & Technology (AREA)
  • Pest Control & Pesticides (AREA)
  • Environmental Sciences (AREA)
  • Dentistry (AREA)
  • Agronomy & Crop Science (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2013545417A 2010-12-27 2011-12-22 グリコフロールを含む経表面局所イソオキサゾリン製剤 Pending JP2014506249A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP10197090 2010-12-27
EP10197090.3 2010-12-27
US201161430241P 2011-01-06 2011-01-06
US61/430,241 2011-01-06
PCT/EP2011/073830 WO2012089623A1 (en) 2010-12-27 2011-12-22 Topical localized isoxazoline formulation comprising glycofurol

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016138739A Division JP6357508B2 (ja) 2010-12-27 2016-07-13 グリコフロールを含む経表面局所イソオキサゾリン製剤

Publications (2)

Publication Number Publication Date
JP2014506249A true JP2014506249A (ja) 2014-03-13
JP2014506249A5 JP2014506249A5 (enExample) 2015-02-05

Family

ID=43920659

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2013545417A Pending JP2014506249A (ja) 2010-12-27 2011-12-22 グリコフロールを含む経表面局所イソオキサゾリン製剤
JP2016138739A Active JP6357508B2 (ja) 2010-12-27 2016-07-13 グリコフロールを含む経表面局所イソオキサゾリン製剤
JP2018115590A Active JP6539384B2 (ja) 2010-12-27 2018-06-18 グリコフロールを含む経表面局所イソオキサゾリン製剤

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2016138739A Active JP6357508B2 (ja) 2010-12-27 2016-07-13 グリコフロールを含む経表面局所イソオキサゾリン製剤
JP2018115590A Active JP6539384B2 (ja) 2010-12-27 2018-06-18 グリコフロールを含む経表面局所イソオキサゾリン製剤

Country Status (18)

Country Link
US (2) US20130274302A1 (enExample)
EP (1) EP2658541B2 (enExample)
JP (3) JP2014506249A (enExample)
KR (2) KR101920476B1 (enExample)
CN (2) CN108125951A (enExample)
AU (1) AU2011351579B2 (enExample)
BR (1) BR112013015498A2 (enExample)
CA (1) CA2822853C (enExample)
DK (1) DK2658541T3 (enExample)
ES (1) ES2908254T3 (enExample)
HU (1) HUE058290T2 (enExample)
MX (2) MX390508B (enExample)
NZ (1) NZ611474A (enExample)
PL (1) PL2658541T3 (enExample)
PT (1) PT2658541T (enExample)
RU (1) RU2602189C2 (enExample)
WO (1) WO2012089623A1 (enExample)
ZA (1) ZA201304515B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022531590A (ja) * 2019-05-03 2022-07-07 インターベット インターナショナル ベー． フェー． 注射可能な医薬組成物及びその使用

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2658542T4 (da) 2010-12-27 2025-08-25 Intervet Int Bv Topisk lokaliseret isoxazolinformulering
PL2658541T3 (pl) * 2010-12-27 2022-04-04 Intervet International B.V. Preparat izoksazoliny do stosowania miejscowego zawierający glikofurol
CN106474120B (zh) 2011-09-12 2020-07-28 勃林格殷格翰动物保健美国公司 包含异噁唑啉活性剂的杀寄生物组合物，其方法和用途
FI128926B (en) 2012-02-06 2021-03-15 Merial Ltd Parasiticidal oral veterinary composition compositions comprising a systemically active agent for the treatment and / or prevention of a parasitic infection or infection in an animal
JO3626B1 (ar) 2012-02-23 2020-08-27 Merial Inc تركيبات موضعية تحتوي على فيبرونيل و بيرميثرين و طرق استخدامها
CA2867079A1 (en) * 2012-03-13 2013-09-19 Bayer New Zealand Limited Long acting compositions
NZ719916A (en) 2013-11-01 2017-09-29 Merial Inc Antiparasitic and pesticidal isoxazoline compounds
EP2875726A1 (fr) * 2013-11-13 2015-05-27 Ceva Animal Health Nouvelles applications de compositions vétérinaires dans le traitement contre les parasites
JP6581586B2 (ja) 2013-12-20 2019-09-25 インターベット インターナショナル ベー． フェー． イソオキサゾリン組成物および動物における寄生虫侵襲の予防または処置におけるその使用
WO2015091900A1 (en) 2013-12-20 2015-06-25 Intervet International B.V. Use of isoxazoline derivatives for the treatment or prevention of arthropod infestations in poultry
CN106455560B (zh) 2014-04-17 2020-12-22 勃林格殷格翰动物保健美国公司 用于保护动物免受寄生物的丙二腈化合物的用途
CN114681453A (zh) 2014-12-22 2022-07-01 英特维特国际股份有限公司 异噁唑啉化合物用于治疗蠕形螨病的用途
UY36570A (es) 2015-02-26 2016-10-31 Merial Inc Formulaciones inyectables de acción prolongada que comprenden un agente activo isoxazolina, métodos y usos de las mismas
SG10201912724SA (en) 2015-04-08 2020-02-27 Boehringer Ingelheim Animal Health Usa Inc Extended release injectable formulations comprising an isoxazoline active agent, methods and uses thereof
MX379719B (es) 2015-05-20 2025-03-11 Boehringer Ingelheim Animal Health Usa Inc Compuestos depsipeptidicos como anthelmínticos.
UY37137A (es) 2016-02-24 2017-09-29 Merial Inc Compuestos antiparasitarios de isoxazolina, formulaciones inyectables de acción prolongada que los comprenden, métodos y usos de los mismos
WO2018039508A1 (en) 2016-08-25 2018-03-01 Merial, Inc. Method for reducing unwanted effects in parasiticidal treatments
CN110381738B (zh) 2016-10-14 2021-07-16 勃林格殷格翰动物保健美国公司 农药的和杀寄生物的乙烯基异噁唑啉化合物
BR112019009977A2 (pt) 2016-11-16 2019-08-27 Boehringer Ingelheim Animal Health Usa Inc compostos depsipeptídicos anti-helmínticos
ES2944616T3 (es) 2017-08-14 2023-06-22 Boehringer Ingelheim Animal Health Usa Inc Compuestos de pirazol-isoxazolina plaguicidas y parasiticidas
BR112020010291A2 (pt) * 2017-11-23 2020-11-17 Ceva Sante Animale composição contendo moxidectina para tratamento de infestações de parasitas
AR113997A1 (es) 2017-12-21 2020-07-08 Intervet Int Bv Composiciones antiparasitarias para unción dorsal continua
EP3820870A1 (en) 2018-07-09 2021-05-19 Boehringer Ingelheim Animal Health USA Inc. Anthelminthic heterocyclic compounds
US11773066B2 (en) 2018-11-20 2023-10-03 Boehringer Ingelheim Animal Health USA Inc. Indazolylcyanoethylamino compound, compositions of same, method of making, and methods of using thereof
CN119285648A (zh) 2019-03-19 2025-01-10 勃林格殷格翰动物保健有限公司 驱虫的氮杂-苯并噻吩和氮杂-苯并呋喃化合物
CA3147431A1 (en) 2019-07-16 2021-01-21 Donaghys Limited Transdermal solvent system and methods of use
WO2021127188A1 (en) 2019-12-18 2021-06-24 Elanco Tiergesundheit Ag Isoxazoline derivatives as pesticides
WO2021242481A1 (en) 2020-05-28 2021-12-02 Boehringer Ingelheim Animal Health USA Inc. Bi-modal release intra-ruminal capsule device and methods of use thereof
CR20220665A (es) 2020-05-29 2023-07-19 Boehringer Ingelheim Pharma Compuestos heterocíclicos como anthelmínticos
EP4185585A1 (en) 2020-07-24 2023-05-31 Elanco Us Inc. Process for making an isoxazoline compound and intermediate thereof
AU2021410052B2 (en) 2020-12-21 2025-01-09 Boehringer Ingelheim Vetmedica Gmbh Parasiticidal collar comprising isoxazoline compounds
US20240116854A1 (en) 2021-01-27 2024-04-11 Intervet Inc. Cyclopropylamide compounds against parasites in fish
CA3209562A1 (en) 2021-01-27 2022-08-04 Intervet International B.V. Cyclopropylamide compounds against parasites in fish
JP2025507585A (ja) 2022-02-17 2025-03-21 ベーリンガー インゲルハイム フェトメディカ ゲーエムベーハー 流体製品メーラーを提供する方法及びシステム
NO20240925A1 (en) 2023-09-15 2025-03-17 Evah Atlantic Inc Dihydroisoxazole compound for use in reducing ectoparasite infestations on fish
WO2025191150A2 (en) 2024-03-15 2025-09-18 Krka, D.D., Novo Mesto Stable isoxazoline formulation for topical application to the skin
WO2025257633A1 (en) 2024-06-12 2025-12-18 Boehringer Ingelheim Vetmedica Gmbh Long-acting castor oil-containing injectable formulations and methods of use thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60123419A (ja) * 1983-11-21 1985-07-02 メイ・アンド・ベーカー・リミテツド 製薬組成物
JP2006522154A (ja) * 2003-04-04 2006-09-28 メリアル リミテッド 動物用駆虫局所製剤
JP2010536733A (ja) * 2007-08-17 2010-12-02 インターベツト・インターナシヨナル・ベー・ベー イソオキサゾリン組成物および駆虫薬としてのそれらの使用
US20100311685A1 (en) * 2007-12-21 2010-12-09 Guy Derrieu Pharmaceutical Composition Containing An N-Phenylpyrazole Derivative And Glycofurol, Use For The Preparation Of A Topical Veterinary Medicament For Combating Fleas

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3950360A (en) 1972-06-08 1976-04-13 Sankyo Company Limited Antibiotic substances
US3984564A (en) 1972-06-08 1976-10-05 Sankyo Company Limited Antibiotic substances B-41, their production and their use as insecticides and acaricides
US4916154A (en) 1986-09-12 1990-04-10 American Cyanamid Company 23-Imino derivatives of LL-F28249 compounds
IL98599A (en) 1990-06-28 1995-06-29 Merck & Co Inc Stable salts of 4"-deoxy-4"-epi-methylamino avermectin b1a/b1b and insecticidal compositions containing them
US5399717A (en) 1993-09-29 1995-03-21 Merck & Co., Inc. Glycosidation route to 4"-epi-methylamino-4"-deoxyavermectin B1
US20050192319A1 (en) † 1996-09-19 2005-09-01 Albert Boeckh Spot-on formulations for combating parasites
US8119150B2 (en) * 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
EP1646445A4 (en) * 2003-07-18 2007-09-19 Baxter Int METHOD OF MANUFACTURING, USING AND COMPOSING SMALL BALLULAR PARTICLES PRODUCED BY CONTROLLED PHASE SEPARATION
WO2005085216A1 (ja) 2004-03-05 2005-09-15 Nissan Chemical Industries, Ltd. イソキサゾリン置換ベンズアミド化合物及び有害生物防除剤
DE102004021281A1 (de) 2004-04-29 2005-11-24 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin
TWI350728B (en) * 2004-10-08 2011-10-21 Wyeth Corp Amitraz compositions
TWI412322B (zh) 2005-12-30 2013-10-21 Du Pont 控制無脊椎害蟲之異唑啉
TWI430995B (zh) 2007-06-26 2014-03-21 Du Pont 萘異唑啉無脊椎有害動物控制劑
EP2957284B1 (en) 2007-06-27 2018-01-17 E. I. du Pont de Nemours and Company Animal pest control method
ES2442342T3 (es) 2008-12-18 2014-02-11 Novartis Ag Derivados de las isoxazolinas y su uso como pesticida
US8383659B2 (en) 2008-12-19 2013-02-26 Novartis Ag Isoxazoline derivatives as pesticides
WO2010128095A1 (en) 2009-05-07 2010-11-11 Novartis Ag Ectoparasiticidal compositions
DK3078664T3 (da) 2009-12-17 2019-05-13 Merial Inc Antiparasitiske dihydroazol-sammensætninger
DK178277B1 (da) * 2010-06-18 2015-10-26 Novartis Tiergesundheit Ag Diaryloxazolinforbindelser til bekæmpelse af fiskelus
PL2658541T3 (pl) * 2010-12-27 2022-04-04 Intervet International B.V. Preparat izoksazoliny do stosowania miejscowego zawierający glikofurol
DK2658542T4 (da) † 2010-12-27 2025-08-25 Intervet Int Bv Topisk lokaliseret isoxazolinformulering
WO2018039508A1 (en) † 2016-08-25 2018-03-01 Merial, Inc. Method for reducing unwanted effects in parasiticidal treatments

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60123419A (ja) * 1983-11-21 1985-07-02 メイ・アンド・ベーカー・リミテツド 製薬組成物
JP2006522154A (ja) * 2003-04-04 2006-09-28 メリアル リミテッド 動物用駆虫局所製剤
JP2010536733A (ja) * 2007-08-17 2010-12-02 インターベツト・インターナシヨナル・ベー・ベー イソオキサゾリン組成物および駆虫薬としてのそれらの使用
US20100311685A1 (en) * 2007-12-21 2010-12-09 Guy Derrieu Pharmaceutical Composition Containing An N-Phenylpyrazole Derivative And Glycofurol, Use For The Preparation Of A Topical Veterinary Medicament For Combating Fleas

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JPN6016009692; 医薬品添加物ハンドブック , 2007, ｐ．２６３-２６４ *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022531590A (ja) * 2019-05-03 2022-07-07 インターベット インターナショナル ベー． フェー． 注射可能な医薬組成物及びその使用
JP7558197B2 (ja) 2019-05-03 2024-09-30 インターベット インターナショナル ベー． フェー． 注射可能な医薬組成物及びその使用
JP2024170642A (ja) * 2019-05-03 2024-12-10 インターベット インターナショナル ベー． フェー． 注射可能な医薬組成物及びその使用
JP7769070B2 (ja) 2019-05-03 2025-11-12 インターベット インターナショナル ベー． フェー． 注射可能な医薬組成物及びその使用

Also Published As

Publication number Publication date
MX390508B (es) 2025-03-20
RU2602189C2 (ru) 2016-11-10
NZ611474A (en) 2015-08-28
MX348079B (es) 2017-05-25
KR20180125618A (ko) 2018-11-23
CA2822853C (en) 2021-05-11
US20130274302A1 (en) 2013-10-17
KR101992589B1 (ko) 2019-06-24
ZA201304515B (en) 2014-03-26
AU2011351579A1 (en) 2013-06-20
MX2013007501A (es) 2013-08-01
JP2016216489A (ja) 2016-12-22
JP6357508B2 (ja) 2018-07-11
CN103260620A (zh) 2013-08-21
RU2013135415A (ru) 2015-02-10
JP6539384B2 (ja) 2019-07-03
EP2658541A1 (en) 2013-11-06
CN108125951A (zh) 2018-06-08
HUE058290T2 (hu) 2022-07-28
EP2658541B1 (en) 2022-01-26
KR20130130762A (ko) 2013-12-02
AU2011351579B2 (en) 2016-04-21
KR101920476B1 (ko) 2018-11-21
BR112013015498A2 (pt) 2016-11-01
MX2019011837A (es) 2019-11-21
PL2658541T3 (pl) 2022-04-04
US20150011596A1 (en) 2015-01-08
ES2908254T3 (es) 2022-04-28
WO2012089623A1 (en) 2012-07-05
JP2018154657A (ja) 2018-10-04
DK2658541T3 (da) 2022-04-04
EP2658541B2 (en) 2025-12-17
CA2822853A1 (en) 2012-07-05
PT2658541T (pt) 2022-03-11

Similar Documents

Publication Publication Date Title
JP6357508B2 (ja) グリコフロールを含む経表面局所イソオキサゾリン製剤
JP6246864B2 (ja) 経表面局所イソオキサゾリン製剤
KR102193090B1 (ko) 국소 적용 이속사졸린 제제

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20141212

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20141212

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20151013

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160112

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20160315